Research Shows A Tiny Nanoparticle Could Have A Significant Impact On Corneal Transplant Patients
The nanoparticle approach reversed signs of early rejection and kept corneal grafts viable for six months
The nanoparticle approach reversed signs of early rejection and kept corneal grafts viable for six months
